The End Game

In this episode of The End Game, Melissa Butterworth explores the strategic timing behind selling a laboratory, highlighting the key factors that can significantly impact valuation. She discusses the importance of thorough preparation, maintaining strong operational performance, understanding market conditions, and assessing personal readiness. The episode underscores that a successful exit isn’t just about when you sell—but how well-positioned your business is when you do

In this episode of The End Game podcast, host Melissa Butterworth shares her personal experience with telemedicine, specifically focusing on the Call On Doc app. She discusses the convenience and accessibility of virtual consultations, highlighting the app's features, pricing, and user satisfaction. The conversation emphasizes the growing importance of telemedicine in providing quick and efficient healthcare solutions, especially for non-emergency situations.

In this episode Melissa Butterworth discusses her involvement with the Cancer Alliance and the importance of fundraising for cancer patients. She transitions into the topic of at-home testing, specifically focusing on Vium, a microbiome testing company that utilizes advanced RNA sequencing and AI to provide personalized health insights. Melissa explains the different tests offered by Vium, including the gut intelligence test, full body intelligence test, and oral health intelligence test, emphasizing their significance in understanding overall health and wellness. She shares her excitement about receiving her test results and encourages listeners to consider at-home testing for better health management.

In this episode of The Endgame podcast, host Melissa Butterworth discusses the importance of at-home health testing, particularly focusing on cholesterol monitoring. She shares personal anecdotes and emphasizes the convenience and empowerment that at-home tests provide for individuals looking to manage their health proactively. The conversation highlights various testing options, their accuracy, and the significance of regular health monitoring in preventing serious conditions like heart disease.

In this episode of the Endgame podcast, host Melissa Butterworth discusses the significance of ColiGuard as a noninvasive alternative for colon cancer screening. She emphasizes the importance of early detection in colorectal cancer and how ColiGuard can empower patients to take control of their health from the comfort of their homes. The conversation highlights the effectiveness of ColiGuard, its ease of use, and its role in increasing screening rates among individuals hesitant about traditional colonoscopy procedures.

In this episode of the End Game Podcast, host Melissa Butterworth discusses the recent transaction between Community Health Systems (CHS) and LabCorp, highlighting its significance for patient care and the healthcare industry. She provides insights into the operational aspects of the deal, the impact on lab services, and the ongoing trend of hospital divestitures in the lab sector. Melissa emphasizes the positive outcomes for patients and the strategic importance of such transactions in enhancing healthcare delivery.

Host Melissa Butterworth, founder of Advanced Strategic Partners and seasoned lab executive, is back for part two of her deep dive into the fast-growing world of direct-to-consumer testing.In this episode, Melissa shares 10 lesser-known at-home health tests that could uncover hidden health issues—from food sensitivities and heavy metals to biological aging and even HPV. Drawing from personal experience and industry insight, she highlights which tests are worth trying, where to find them, and how they’re helping people take control of their health from the comfort of home.If you’ve ever dreaded a colonoscopy or postponed your annual visit to the OBGYN, this episode is for you. Discover the “hidden gems” in at-home testing that could make all the difference for you or someone you love.🎧 Listen now on Spotify or at www.advancedstrategicpartners.com

In this conversation, Melissa Butterworth discusses the rise of direct-to-consumer testing, emphasizing how it empowers patients to take control of their health. She likens the market to Netflix, highlighting its convenience and personalization.

In this special solo episode of End Game: Insiders on Your Side, host Melissa Butterworth takes listeners behind the scenes of her own career journey—from pharmaceutical sales to leading one of the nation’s top M&A firms for laboratories. With her extensive background in sales, Melissa dives deep into the many sales and business development opportunities within the laboratory diagnostic industry.From entry-level diagnostic sales representatives to high-stakes strategic account executives, Melissa breaks down the responsibilities, skills, and compensation ranges for each role. Whether you’re exploring a career in lab sales, considering a transition, or simply curious about how sales drives the diagnostics field, this episode offers valuable insight into an industry that continues to grow at 8% annually.Tune in to learn: ✔ The different sales career paths in diagnostics ✔ Salary ranges across positions and markets ✔ Skills needed to succeed in each role ✔ Where the industry is heading and how to network your way in

In this episode of the Endgame Podcast, host Melissa Butterworth discusses the major challenges laboratories are facing in 2025, including staffing shortages, compliance pressures, and supply chain issues. She emphasizes the need for innovation and proactive strategies to navigate these hurdles, such as embracing automation, building partnerships, and investing in training programs.

In this episode, Melissa Butterworth discusses the current state and future of the clinical laboratory industry, highlighting its significance in medical decision-making, the types of labs, and the impact of technology and consolidation on the market.

In this episode of the Endgame podcast, Melissa Butterworth discusses the transformative impact of AI on the laboratory diagnostic industry. She explores how AI enhances diagnostic precision, streamlines workflows, and supports personalized medicine. The conversation highlights the significant growth of AI in pathology and its potential to revolutionize lab operations, making them more efficient and effective. Melissa emphasizes the urgency for labs to embrace AI technology to stay competitive in the evolving healthcare landscape.

In this inspiring episode of The End Game: Insiders on Your Side, host Melissa Butterworth sits down with Ravi Pulugurtha, Vice President of Operations at G3 Vision Labs, to explore the bold vision of delivering better healthcare everywhere for everyone.Ravi shares his journey from leading roles in healthcare technology to his current mission of transforming diagnostics—making them faster, more accessible, and patient-centric. He discusses how COVID-19 exposed the urgent need for timely test results, why now is the perfect time for innovation in healthcare, and the bold steps G3 Vision Labs is taking, including plans to go public, launching a patient-focused mobile app, and integrating AI to reduce errors.Listeners will gain insight into:How rapid diagnostics can save lives and improve patient outcomesG3 Vision Labs’ commitment to quality, trust, and transparencyThe importance of staying true to values during rapid growthThe long-term vision for equitable, efficient, and responsive healthcareWhether you’re a senior lab executive, healthcare innovator, or simply passionate about improving patient care, this conversation will leave you inspired about the future of diagnostics.

How can artificial intelligence turn lab data into life-changing patient outcomes? In this episode of The End Game Insiders podcast, host Melissa Butterworth sits down with Brad Bostic, CEO of HC1, to explore how AI-powered healthcare analytics is reshaping the way we deliver care.From optimizing lab operations to driving value-based care, Brad shares how AI can:Personalize patient care through lab-driven insightsIdentify care gaps before they become crisesImprove operational efficiency and supply chain managementHelp healthcare systems deliver better outcomes at lower costsSound bites from the episode: 💬 "The lab is the place where the most value is—in its information." 💬 "It's all about how you maximize the value of these lab capabilities." 💬 "We are seeing a substantial shift toward value-based care."Whether you’re in healthcare leadership, lab operations, or passionate about the potential of healthcare technology, this episode offers a data-driven look at how AI is transforming the industry.🎧 Listen now and see how the future of healthcare is being built today.#AI #HealthcareAnalytics #LabOperations #ValueBasedCare #HC1 #HealthcareInnovation #PatientCare #HealthcareTechnology #SupplyChainManagement

Join host Melissa Butterworth on "The End Game" as she explores the dynamic landscape of hospital systems and their strategic decisions to divest outreach programs. In this episode, Melissa discusses the financial, operational, and regulatory challenges prompting hospitals to reconsider their involvement in laboratory diagnostics. Learn about the significant transactions reshaping the industry. Tune in for an in-depth analysis of the healthcare market and its evolving priorities. 

In this episode, host Melissa Butterworth sits down with Matt Honan, Vice President of Business Development at Sonic Healthcare, to explore why more and more health systems are choosing to monetize their lab outreach programs, enter management arrangements, and seek strategic partners.Together, they unpack what successful relationships between health systems and commercial labs really look like—from cultural alignment to long-term strategic value. Matt shares his insights into how buyers evaluate hospital outreach businesses, the key drivers behind higher valuations, and why these deals often take longer and look very different than traditional M&A transactions.

In this episode of The End Game podcast, host Melissa Butterworth interviews Ravi Pulagurtha, Vice President of G3 Vision Labs. They discuss the vision for better healthcare for everyone, the importance of timely diagnostics, and how G3 Vision Labs is redefining trust in medical testing. Ravi shares insights on the innovative steps the lab is taking to improve patient access and care, while maintaining integrity and values during growth. The conversation highlights the role of technology and continuous improvement in transforming healthcare delivery.

In this episode, Melissa Butterworth discusses the importance of not accepting direct offers for lab sales without going through a comprehensive six-step M&A process. She emphasizes the need for lab owners to evaluate their offers in the market to maximize their lab's value. Drawing from her personal experience as a lab owner, she shares insights on how competition can lead to better offers and encourages listeners to reach out for more information on the M&A process.

In this episode of the Endgame podcast, Melissa Butterworth discusses the key factors that influence the valuation of laboratories when they are taken to market. She emphasizes the importance of understanding the type of buyer, the impact of revenue compression, and the significance of lab type and location. The conversation provides insights into why lab owners should consider multiple offers and the dynamics of the healthcare market.

In this episode, Melissa Butterworth discusses the founding of Advanced Strategic Partners, highlighting her extensive experience in the laboratory industry and the unique differentiators of her firm. She elaborates on the services offered, including valuation and operational assessments, and emphasizes the importance of insider connections in maximizing laboratory value.

In this episode of The End Game podcast, host Melissa Butterworth speaks with John David Klipp about the evolving landscape of hospital outreach transactions. They discuss the recent surge in hospital systems considering divestment of their lab operations due to financial pressures, the perspectives of hospital executives, and the challenges faced in understanding the true value of laboratory assets. The conversation also touches on the concerns of pathologists regarding potential changes in control and the alternative strategies being pursued by companies like Quest Diagnostics and LabCorp.

In the latest episode of The End Game Podcast, host Melissa Butterworth takes a deep dive into the evolving M&A landscape for laboratories as we head into 2025. From the rise of larger transactions to the types of acquisitions shaping the industry, Melissa breaks down the key trends lab owners need to know.She also shares insights from her published works, offering practical strategies to help lab owners successfully navigate the M&A process and maximize their outcomes.Whether you're considering an acquisition, preparing for a sale, or just keeping a pulse on the market—this episode is packed with valuable takeaways.

In this episode of The End Game, Melissa Butterworth explores the critical role of timing in laboratory sales. She shares a real-life case study that illustrates how market decisions can significantly impact financial outcomes. Melissa emphasizes the importance of working with specialized M&A advisory firms to navigate the complexities of the industry and ensure lab executives maximize their organization's value.

In the latest episode of The End Game, Melissa Butterworth sits down with attorney Jane Pine wood to unpack the critical legal and compliance issues facing pathology practices and laboratories.From billing due diligence to sales and marketing regulations, licensure complexities, and payer contracts—Jane shares expert insights on how to avoid costly missteps that could devalue a practice. Transparency during transactions is key, and having the right legal counsel can make all the difference in navigating the evolving healthcare landscape.If you’re in the lab industry, this is an episode you won’t want to miss!

In this episode of the End Game Insiders podcast, Melissa Butterworth interviews Adam Earl, a former lab owner who shares his experiences navigating the M&A process in the lab industry. Adam discusses his journey from entering the lab business to successfully selling his lab amidst the challenges posed by the COVID-19 pandemic. He emphasizes the importance of building strong customer relationships, the role of investment bankers, and the lessons learned throughout the M&A process. Adam also highlights the significance of patience, adaptability, and the value of relationships in securing successful transactions. Looking ahead, he expresses his desire to help other lab owners navigate similar challenges in the future.

Learn from the best with this HFMA webinar! This episode goes over the current hospital laboratory market and gain insight on:Understand current market dynamics and what they mean for your organizationDevelop an effective approach to determine the best going forward model for your lab operationsUnderstand the components and time frame of a transactionGain insight into the key transaction business, operational and legal issues

In this episode of The End Game podcast, host Melissa Butterworth reflects on the past year and introduces her new book, which focuses on the exit strategies for hospital laboratories. She discusses the significant trends in hospital lab transactions, the challenges faced by hospital systems, and the importance of understanding the M&A process for maximizing the value of laboratory assets. The episode concludes with a look ahead to 2025 and the exciting content planned for the podcast.

In this episode, Melissa speaks with Founder of Olive and Birdie Marketing, Olivia Huff and they dive deep into the critical role branding and marketing play in the success of any business. From creating a strong emotional connection with your audience to effectively marketing your services, they explore why these elements are the foundation for sustainable growth. Whether you're a startup or an established business, this episode offers actionable insights on how to enhance your brand identity and marketing strategy for long-term success.

In this episode of the End Game podcast, Melissa Butterworth shares the top five habits of the most successful salespeople, drawing from her personal experiences and insights from John Maxwell. She emphasizes the importance of self-improvement, goal setting, and creating a structured routine to achieve success in sales and life.

In this episode, Melissa Butterworth discusses two key areas that lab owners need to focus on before taking their lab to the market: financials and compliance. She emphasizes the importance of having three years' worth of P&L statements, cash flow statements, and balance sheets in order. In terms of compliance, she highlights the importance of having a thorough compliance policy, handbook, training, and hotline. Melissa advises lab owners to work with a reputable M&A firm to ensure compliance and have all necessary documents stored in a cloud-based environment.

In this episode of The End Game, Melissa Butterworth interviews Dr. Heather Signorelli about lab stewardship, exploring its significance in healthcare. Dr. Signorelli shares her journey in creating lab stewardship programs, the challenges faced, and the importance of evidence-based guidelines. The conversation emphasizes the need for multidisciplinary teams and strong physician leadership to ensure successful implementation. Dr. Signorelli also discusses the positive impacts of lab stewardship on clinical testing and patient care, highlighting metrics and outcomes that demonstrate its effectiveness.

In this episode, Melissa Butterworth discusses the state of the lab market in 2024. She highlights two major trends: larger transactions and hospital outreach transactions. She also mentions the continued interest and deals in the pathology space and the positive sign of mid-sized clinical lab transactions. Melissa provides insights into the multiples for pathology and clinical laboratory deals and emphasizes the importance of having a M&A advisor. Overall, she concludes that it is a positive time for lab owners considering exiting the space.

In this weeks episode of "The End Game" Melissa sits down with Denise Bennett, an expert in medical billing and revenue cycle management. She shares her journey in the lab industry and the importance of cleaning up accounts receivable (AR) before mergers and acquisitions. She emphasizes the need for compliance in revenue cycle management and the impact of AI in the industry. Denise also discusses the steps necessary for a successful AR cleanup and the timeframe it takes. She concludes by expressing her desire to give back to the industry and provides her contact information.

In this episode, Melissa Butterworth discusses recent trends in the laboratory diagnostic industry, specifically focusing on M&A transactions, numbers of transactions, valuations, and trends in multiples. She highlights the projected growth in national spending on clinical lab testing and the impact of pricing pressures on the industry. Melissa also analyzes the trends in different types of laboratory transactions, such as anatomical pathology, molecular diagnostic, clinical, hospital outreach, and other laboratories. She emphasizes the increase in larger-sized transactions and the high multiples observed in recent years. Melissa concludes by encouraging listeners to seek the expertise of experienced M&A firms in the lab industry.

In this episode, host Melissa Butterworth interviews Robert Michel, founder of the Dark Report and host of the Executive War College, about the current state of the clinical lab industry marketplace. They discuss the challenges and changes in the industry, including hospital and health system finances, data transparency and portability, cybercrime, and the shortage of lab staff. They also touch on the impact of AI in the lab industry and the future of value-based reimbursement models. Overall, the conversation provides valuable insights into the current state and future direction of the clinical lab industry.

In this episode of The End Game podcast, Melissa Butterworth discusses the topic of due diligence in lab acquisitions. She explains that the typical due diligence process can last anywhere from 30 to 90 days, but it can be longer depending on various factors. Melissa emphasizes the importance of having all documents in order before going to market and highlights the difference between simultaneous sign and close deals and non-simultaneous deals. She also provides an overview of the top items that are requested during due diligence, covering categories such as organizational documents, real estate, personal property, operations, accounts receivables, personnel, retirement plans, welfare plans, financial and accounting records, taxes, bank and credit arrangements, insurance agreements, information technology, marketing, billing, HIPAA, environmental matters, litigation, and prior business acquisitions.

In this episode, Dr. Aamir Ehsan discusses the role of pathologists as the quarterbacks of healthcare. He explains the extensive training and expertise of pathologists and how their work impacts patient care. Dr. Ehsan also shares insights into the advancements in laboratory technology and how CorePath, his organization, leverages these advancements. He discusses the decision-making process for investing in technology and the importance of embracing innovation. Additionally, Dr. Ehsan highlights the efforts of CorePath in serving underserved communities and their global initiatives. He concludes by offering advice to aspiring pathologists and emphasizing the importance of passion and dedication in the field.

In this episode, host Melissa Butterworth and guest Christal Contini, a  senior partner with McDonnell Hopkins law firm, discuss the true economics of lab transactions. They cover topics such as taxes, corporate structure, earn-outs, escrows, and purchase price adjustments. They emphasize the importance of involving accountants and tax attorneys early in the process to ensure a clear understanding of the financial implications of a deal. The conversation highlights the need for careful negotiation and preparation to avoid pitfalls and maximize value for sellers.

In this episode, host Melissa Butterworth interviews Gary Huff, a seasoned lab executive with over 30 years of experience in the industry. They discuss the changing landscape of the lab industry over the past few decades and the challenges and opportunities it presents. Gary shares his insights on the importance of specialization and focusing on specific areas of the industry, as well as the need for compliance and strong business practices when preparing to sell a lab. The conversation highlights the impact of automation and technology on the industry and the importance of staying ahead of the curve.

In this episode, Melissa Butterworth dives deep into the final three steps of the proven 6-step mergers and acquisitions process for laboratories. Step 4 is Marketing the Business, step 5 is letters of intent and due diligence, and step 6 is definitive purchase agreements and closing.Throughout the episode, Melissa emphasizes the importance of hiring the right advisors, staying organized, and keeping the momentum going. It's a must-listen for anyone involved in laboratory mergers and acquisitions!

In the latest episode of The End Game, Melissa Butterworth delves into the first 3 steps of the proven 6-step merger and acquisition (M&A) process tailored specifically for lab owners. If you're contemplating selling your lab, this episode is a must-listen!

In this episode of The End Game Podcast, host Melissa Butterworth interviews Emily Johnson, a healthcare regulatory partner at McDonald Hopkins. They discuss recent regulatory and enforcement actions impacting laboratories and pathology groups. Emily highlights the recent enforcement trends and how labs and pathology groups can prevent an investigation and what to do if they do get investigated. She also discusses the impact of investigations on the ability to sell a business and the importance of proactive preparation for due diligence.

 In this episode, Melissa delves into a critical topic for laboratory owners: the strategic choices between selling independently versus engaging a business banker or M&A advisory firm. Choosing the right path for selling your laboratory can be a game-changer. Melissa expertly dissects the advantages and disadvantages of both approaches, providing invaluable guidance for navigating this pivotal decision. Whether you're weighing the benefits of maintaining full control over the selling process or seeking the expertise and connections of professionals, Melissa's insights offer a roadmap for success. Don't miss out on this essential discussion that could shape the future of your laboratory business.

In this episode, Melissa Butterworth discusses the concept of due diligence in M&A transactions. Melissa covers various areas that are examined during due diligence, including financials, incorporation documents, employee benefits, compliance programs, customer contracts, intellectual property, and more. She also provides recommendations on what not to share during due diligence and advises against non-simultaneous sign and close arrangements.

In this week's episode, Melissa Butterworth interviews Jeff Myers, Vice President of Consulting and Strategic advisory services for Accumen. They discuss the importance of understanding lab test complexity in both acute care and ambulatory lab testing settings. They also discuss the importance of department-level reporting for lab costs and lab volume as well as building a Laboratory Relative Value Unit (RVU) system. They explore the relationship between lab test mix and hospital case mix index.

In this podcast episode, Jim Billington, CEO and co-founder of Versant Diagnostics, discusses the impact of digital pathology on the laboratory diagnostic landscape. He shares his background and the founding of Versant Diagnostics, highlighting the mission to drive the adoption of digital pathology for better patient outcomes. 

In this episode, Melissa Butterworth and Rick Cooper discuss hospital lab transactions and key negotiation must-haves. They highlight the current appetite for hospital lab transactions and the reasons why hospitals are selling labs or seeking management agreements. They emphasize the importance of negotiating protections for quality lab services and the use of performance metrics as protection in hospital deals. They also discuss the problems that can arise post-transaction and the causes behind them. The episode concludes with final thoughts on assessing the marketplace and making informed decisions.

In this episode, Melissa Butterworth discusses the differences between asset and stock transactions in lab M&A deals and how they can affect valuation. She also explains the two types of buyers in the market: strategic buyers and non-strategic buyers. Strategic buyers are more likely to pay maximum value for a lab due to the synergies they can recognize between their entity and the one being sold. On the other hand, non-strategic buyers may pay based on a standard multiplier of adjusted EBITDA. Melissa emphasizes the importance of a competitive process in negotiating the price and achieving maximum valuation.

In this episode of The Endgame podcast, Melissa Butterworth discusses the seven key attributes that define a quality lab from the eyes of a buyer.  The host provides insights and tips for lab owners who are considering selling their lab, highlighting the importance of these attributes in attracting buyers and increasing the value of the lab.

In this episode of The Endgame podcast, Melissa Butterworth discusses the topic of valuation and how to prepare for maximum valuation when selling a lab. The conversation is divided into 10 key steps that should be implemented or considered prior to selling a lab.